May 6, 2020 / 9:55 PM / 23 days ago

BRIEF-Cellular Biomedicine Reports Q1 Loss Per Share Of $0.60

May 6 (Reuters) - Cellular Biomedicine Group Inc:

* CELLULAR BIOMEDICINE GROUP REPORTS Q1 2020 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

* CELLULAR BIOMEDICINE GROUP INC - QTRLY LOSS PER SHARE $0.60 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below